These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

440 related items for PubMed ID: 9826275

  • 1. Transient developmental expression of monoamine transporters in the rodent forebrain.
    Lebrand C, Cases O, Wehrlé R, Blakely RD, Edwards RH, Gaspar P.
    J Comp Neurol; 1998 Nov 30; 401(4):506-24. PubMed ID: 9826275
    [Abstract] [Full Text] [Related]

  • 2. Changing distribution of monoaminergic markers in the developing human cerebral cortex with special emphasis on the serotonin transporter.
    Verney C, Lebrand C, Gaspar P.
    Anat Rec; 2002 Jun 01; 267(2):87-93. PubMed ID: 11997877
    [Abstract] [Full Text] [Related]

  • 3. The role of membrane and vesicular monoamine transporters in the neurotoxic and hypothermic effects of 1-methyl-4-(2'-aminophenyl)-1,2,3,6-tetrahydropyridine (2'-NH(2)-MPTP).
    Numis AL, Unger EL, Sheridan DL, Chisnell AC, Andrews AM.
    Mol Pharmacol; 2004 Sep 01; 66(3):718-27. PubMed ID: 15322265
    [Abstract] [Full Text] [Related]

  • 4. Norepinephrine transporter (NET), serotonin transporter (SERT), vesicular monoamine transporter (VMAT2) and organic cation transporters (OCT1, 2 and EMT) in human placenta from pre-eclamptic and normotensive pregnancies.
    Bottalico B, Larsson I, Brodszki J, Hernandez-Andrade E, Casslén B, Marsál K, Hansson SR.
    Placenta; 2004 Jul 01; 25(6):518-29. PubMed ID: 15135235
    [Abstract] [Full Text] [Related]

  • 5. Rapid and differential losses of in vivo dopamine transporter (DAT) and vesicular monoamine transporter (VMAT2) radioligand binding in MPTP-treated mice.
    Kilbourn MR, Kuszpit K, Sherman P.
    Synapse; 2000 Mar 15; 35(4):250-5. PubMed ID: 10657034
    [Abstract] [Full Text] [Related]

  • 6. Vesicular neurotransmitter transporters in Huntington's disease: initial observations and comparison with traditional synaptic markers.
    Suzuki M, Desmond TJ, Albin RL, Frey KA.
    Synapse; 2001 Sep 15; 41(4):329-36. PubMed ID: 11494403
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Vesicular amine transporter expression and isoform selection in developing brain, peripheral nervous system and gut.
    Schütz B, Schäfer MK, Eiden LE, Weihe E.
    Brain Res Dev Brain Res; 1998 Mar 12; 106(1-2):181-204. PubMed ID: 9555003
    [Abstract] [Full Text] [Related]

  • 12. Region-specific targeting of dopamine D2-receptors and somatodendritic vesicular monoamine transporter 2 (VMAT2) within ventral tegmental area subdivisions.
    Pickel VM, Chan J, Nirenberg MJ.
    Synapse; 2002 Aug 12; 45(2):113-24. PubMed ID: 12112404
    [Abstract] [Full Text] [Related]

  • 13. Developmental regulation of early serotonergic neuronal differentiation: the role of brain-derived neurotrophic factor and membrane depolarization.
    Eaton MJ, Staley JK, Globus MY, Whittemore SR.
    Dev Biol; 1995 Jul 12; 170(1):169-82. PubMed ID: 7601307
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Localization and dynamic regulation of biogenic amine transporters in the mammalian central nervous system.
    Hoffman BJ, Hansson SR, Mezey E, Palkovits M.
    Front Neuroendocrinol; 1998 Jul 12; 19(3):187-231. PubMed ID: 9665836
    [Abstract] [Full Text] [Related]

  • 16. Catecholamine reuptake and storage. Overview.
    Bönisch H, Eiden L.
    Adv Pharmacol; 1998 Jul 12; 42():149-64. PubMed ID: 9327868
    [No Abstract] [Full Text] [Related]

  • 17. Ontogeny of vesicular monoamine transporter mRNAs VMAT1 and VMAT2. I. The developing rat central nervous system.
    Hansson SR, Hoffman BJ, Mezey E.
    Brain Res Dev Brain Res; 1998 Sep 10; 110(1):135-58. PubMed ID: 9733951
    [Abstract] [Full Text] [Related]

  • 18. 3,4-methylenedioxymethamphetamine (MDMA) administration to rats decreases brain tissue serotonin but not serotonin transporter protein and glial fibrillary acidic protein.
    Wang X, Baumann MH, Xu H, Rothman RB.
    Synapse; 2004 Sep 15; 53(4):240-8. PubMed ID: 15266556
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Expression of the vesicular glutamate transporters during development indicates the widespread corelease of multiple neurotransmitters.
    Boulland JL, Qureshi T, Seal RP, Rafiki A, Gundersen V, Bergersen LH, Fremeau RT, Edwards RH, Storm-Mathisen J, Chaudhry FA.
    J Comp Neurol; 2004 Dec 13; 480(3):264-80. PubMed ID: 15515175
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.